Background: Testis-specific gene antigen (TSGA10) mainly involves in spermatogenesis and embryogenesis. In the new defined roles, being a tumor suppressor agent or a cancer/testis antigen (CTA) is still unclear for this protein. The current study aimed to examine exact role of TSGA10 as a tumor suppressor or CTA in breast cancer and evaluate the role of microenvironment on its expression.
HIF-1α expression was up-regulated in both normoxic (P<0.01) and hypoxic (P<0.01) conditions. Also, TSGA10 expression increased up to 7.39±0.156 folds in MCF-7 cells after HDACI treatment (all P<0.01). However, MDA-MB23 cells firstly experienced a decrease and then a notable increase in TSGA10 expression (all P<0.01).
Conclusion: Results of current study showed that TSGA10 seems to be tumor suppressor, however, further studies are necessary.
Background
Testis-specific gene antigen (TSGA10) is a role player factor during embryogenesis and spermatogenesis. This gene which is located on chromosome 2 (2q11.2) encodes a 3 Kb mRNA that translates to a polypeptide with a molecular weight of 82 kDa [1] [2] [3] . After posttranslational modifications, the protein converts to the two segments including 27 (Nterminus fragment) and 55 kDa (C-terminus fragment) polypeptides. With an eye on the functional role, C-terminus places in the midpiece and the N-terminus fragment presents in the fibrous sheath of sperm tail [4] . Although this gene expresses in the physiological situations, it is also involved in some pathological conditions such as tumors and autoimmune diseases. As it has been reported, over-expression of TSGA10 has been seen in some malignancies, and thus, it has been categorized as cancer/testis antigen (CTA) [5, 6] . However, new studies in this field show different results. The lower expression levels of TSGA10 in cancer cells [7] , as well as its ability to decrease cell motility and invasion [6] , is totally against its CTA role. These results provide a debatable issue on the exact role of TSGA10 in cancer as CTA or tumor suppressor agent.
According to the data, the C-terminus fragment of TSGA10 is co-located with hypoxiainducible factor 1α (HIF1-α) and could prevent its nuclear localization [8] . HIF1-α is rapid response cytokine to the low oxygen levels in cellular microenvironment (such as a tumoral tissue) which could be expressed from a variety of cells. This cytokine has been considered as a pro-angiogenic factor and one of the most important beginners of angiogenic cascade. The increased levels of HIF-1α following hypoxia induces overexpression of different pro-angiogenic factors such as vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and erythropoietin which lead to the angiogenesis [9] [10] [11] . Thus, expression of HIF1-α finally leads to activation of angiogenesis cascade and the newly formed micro-vessels provide enough oxygen and nutrient supply for cellular growth. Taken together, data prove crucial of HIF-1α in tumor growth, invasion, and metastasis [12] .
In the current study, it was tried to examine the accurate function of TSGA10 in breast cancer and its possible association with HIF-1α expression status in different microenvironmental conditions.
Methods

Ethical considerations
This study was approved by the Medical Ethics Committees of the affiliated Research Center and Hospital. All the patients participated in the current study, signed a consent form freely after explanation of aims and methods according to their knowledge. Also, all of the authors adhered to the 1975 Declaration of Helsinki and its next revisions.
Patients and samples
Inclusion criteria for sample selection considered as any patients previously diagnosed with breast cancer through histopathological evaluations performed on tissues obtained from core/fine needle biopsies. Also, a positive history of chemotherapy, autoimmune diseases, radiotherapy, and any chronic diseases were defined as exclusion criteria. For the included patients, all of the histopathological evaluations were performed by two wellexperienced pathologists on core/fine needle biopsy samples as well as provided tissues following the surgeries. Also, the control sample for each patient obtained from the histopathological approved tumor-free margin (paired control) and samples obtained from the reduction mammoplasty (unpaired controls). All the samples stored at -80º C in liquid nitrogen for the investigations.
Cell culture
In order to compare TSGA10 expression levels, MCF-7 [13] and MDA-MB231 [14] as breast cancer and MCF10A [15] as a normal cell line were cultured (all purchased from Pasture Institute, Tehran, Iran). The cells were cultured in DMEM/F12 medium supplemented with 10% bovine calf serum (BCS) containing 100 U/ml penicillin and 100 µg/ml streptomycin.
Cells were maintained at 37°C in a humidified incubator with 5% CO2.
Induction of hypoxia
In order to induce hypoxic situation, cells were treated with cobalt (II) chloride hexahydrate (CoCl2.6(H 2 O), MW=237.92 g/mol. MCF-7, MDA-MB23, and MCF10A cells were counted in equal numbers using hemocytometer and planted on a 6 well plate in two replications. They have cultured in the DMEM/F12 medium supplemented with 10% BCS containing 100 U/ml penicillin and 100 µg/ml streptomycin and synchronal treated with 100 µM cobalt (II) chloride hexahydrate for 24 hours [16] . After the mentioned time period RNA extraction was performed.
Inhibition of histone deacetylase
In this study, sodium valproate was used as a histone deacetylase inhibitor (HDACI) in order to evaluate the role of epigenetic changes in the expression of TSGA10 [17] . The malignant cells were treated with different concentrations (0.1, 0.2 and 0.4 mM) of this HDACI in the same situation as previous sections. After 24 hours of treatment with sodium valproate, the BCS free medium was added and RNA extraction performed 18 hours later.
Induction of oxidative stress
The cells were counted in equal numbers using hemocytometer and planted on a 6 well 6 plate in two replications in DMEM/F12 medium supplemented with 10% BCS containing 100 U/ml penicillin and 100 µg/ml streptomycin for 24 hours. Then, the same BCS-free medium containing different concentrations of H 2 O 2 (10, 100, and 200 μM) was added for induction oxidative-stress. The RNA extraction was performed separately in 30 minutes and 24 hours after the treatment.
Lactate assay
In order to investigate cellular proliferation lactate levels were evaluated in each of the three cell lines (MCF-7, MDA-MB231, and MCF-10A). Cells were cultured as same as the previous section but under both hypoxic and normoxic situations. In each of the mentioned situations, all the cultured cells were treated with low and normal amount of glucose. After 24 hours the supernatant was removed and the same media but without BCS was added. Following another 24-hour interval, lactate levels were evaluated according to the manufacture's instruction (Greiner lactate colorimetric LOD-PAP-Test, Monoreagent, Germany).
Real-time PCR
All of the obtained tissues from surgeries (tumor tissue and controls), as well as cultured cells (with and without oxidative-stress, hypoxic induction, and low-glucose condition), were washed with sterile phosphate-buffered saline (PBS) and homogenized using liquid nitrogen. Total RNA extraction was performed using TRIzol ® reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacture's instruction.
Sense and antisense primers for TSGA10 and HIF-1α were designed by robust primer design software as shown in Table 1 . The real-time polymerase chain reaction (PCR) was performed using Takara Kit by Rotor Gene 6000 system (Corbett Research, Australia) on the collected samples and the mentioned 3 cell lines. This method was performed as we 7 have previously discussed in a same research [6] . After data gathering, the collected realtime PCR results from both normal and cancerous cells were compared and evaluated as normalized ratio.
Immunoblotting
For the evaluation of protein levels, western blotting protein analysis was used. For this aim, 40 µg of whole-cell total protein of each sample was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing condition in 8-10% gradient gel. Then, the proteins were transferred to a polyvinylidene fluoride membrane and incubated for 2 hours at 24ºC with blocking buffer (5% non-fat milk dissolved in PBS).
For the detection of TSGA10, goat anti-TSGA10 antibody (Santa Cruz, USA) was used and the membranes were incubated for 24 hours at 4°C. After two times of membranes washing with PBS (5 minutes), membranes have been incubated with the secondary antibody (Santa Cruz, USA) for 2 hours at room temperature. Then after, they were rewashed and using horseradish peroxidase-conjugated reaction the TSGA10 bond visualized. The quantitation of TSGA10 band intensity was performed by TotalLab Life Science Image Analysis Software, Version 2.0 (TotalLab Ltd, Newcastle upon Tyne, UK) through normalization with β-actin protein.
Statistical analysis
Data analyses were performed by GraphPad Prism software 5.0 (GraphPad Software, San Diego, CA). Analyzed data reported as mean±standard deviation (SD) and evaluated by the t-test, one way or two-way analysis of variance (ANOVA) followed by the Tukey test.
Any P-value less than 0.05 was considered to be statistically significant. In the figures showing the significance levels were followed by *P < 0.05, ** P < 0.01, ***P < 0.001. As the results showed, TSGA10 expression in the surgically obtained tumoral tissue samples had 1.38± 0.014 folds of decrease compared with their paired controls (P<0.001).
However, TSGA10 expression in the tumoral tissues compared with unpaired controls showed a 1.41±0.127 fold of increase (P<0.001).
In the in-vitro evaluations, cell lines were challenged with both normoxic and hypoxic situations. It was shown that in the normoxic situation the expression of TSGA10 in MCF-7
and MDA-MB23 cell lines were 4.9±0.283 (P<0.0001) and 4.21±0.163 (P<0.0001) folds lower (respectively) than the control (MCF-10A). Also, it was revealed that in the hypoxic situation the expression of TSGA10 had 4.7±.0.283 (P<0.0001) and 7.1±0.141 (P<0.0001) folds of decrease in MCF-7 and MDA-MB23 cells (respectively) in comparison to the control (Figure 1) .
Moreover, according to the results of western blotting (Figure 2) Figure 3B ).
According to the results, treating cancer cell line (MCF-7 which according to the Figure   3B showed more sensitivity to the environmental changes) was the next aim of this study.
It was shown that induction of oxidative stress significantly increased TSGA10 expression (details in Figure 3C ).
As mentioned, the tumoral tissues showed a significant decrease in TSGA10 expression in comparison to the paired controls. Furthermore, the ROC curve analysis of TSGA10 expression in tumoral and their paired controls reached an AUC of 0.889 (95% CI, 0.780-0.998; P<0.001). Also, the optimal cut off value for expression TSGA10 was defined as 1.604 with the sensitivity and specificity of 86.7 and 100% respectively (Figure 4) .
Discussion
Breast cancer is known as the most prevalent malignancy among women. According to the data, a higher rate of incidence of this cancer has been expected in the next years [18] .
As well as other malignancies, better understanding of any factor affecting the disease could help to improve diagnostic tools, treatments, and survival predictors. The results of current study showed a significant decrease in TSGA10 expression in the cell lines as well as obtained tumoral tissues in comparison to their already defined controls. However, for tumoral tissues, an increase of expression in TSGA10 was observed when compared to the unpaired controls (normal healthy individuals). The most possible hypothetical cause of this paradoxical result seems to the genetic differences between the controls. Considering this hypothesis comparing the results only with the paired controls seems to be more trustable than the unpaired ones. Moreover, there is another hypothesis which considers TSGA10 as a tumor resistance factor. During the tumoral situation, the expression of TSGA10 as a tumor suppressive agent would be increased through the changes in the microenvironment, however, this resistance may be less in the tumoral tissue than their neighbors but higher in comparison to the healthy individuals. This theory is congruent with the previously reported anti-tumoral and anti-angiogenic activity of TSGA10 [6, 7] and the current obtained results. Furthermore, results of in-vitro evaluation on two breast cancer cell lines compared to normal healthy control showed a statistically significant decrease in TSGA10 expression indicates the more probability of the second hypothesis.
Taken together, the paired samples were chosen as the tumoral tissue controls for further evaluations. In the next step, the protein levels of TSGA10 were assessed. The immunoblotting results showed a significant decrease in TSGA10 protein level in tumoral 11 tissue compared with paired control which was along with the gene expression status.
In a similar study by Dianatpour et al. [19] , it was shown that TSGA10 is up-regulated in patients with breast cancer in comparison to the adjacent noncancerous tissue. Their results showed expression of TSGA10 in 70% (N=35/50) using semi-nested PCR (only 10% positive expression in the first RT-PCR) but no expression (0/50) in the adjacent noncancerous tissue. Moreover, they mentioned the positive expression of TSGA10 in MCF- such as vascular endothelial growth factor (VEGF), matrix metalloproteinase 2 (MPP-2), MMP-9, and Chemokine (C-X-C motif) Receptor 4 (CXCR4). Furthermore, they have stated that TSGA10 could be involved in tumor angiogenesis and metastasis but not as an inducer and promoter [6] . In another study, Hagel et al. investigated a direct proteinprotein interaction between TSGA10 and HIF-1α. According to their results, the C-terminus segment of TSGA10 prevents HIF-1α nuclear localization as well as transcriptional activity through an interaction with the N-terminal domain of HIF-1α [8] .
During tumor growth, the micro-environment is not able to provide enough nutrition and oxygen for cellular survival and proliferation. As a response, HIF-1α starts the angiogenic cascade in order to overcome this situation [21] . According to the different studies, hypoxia could lead to the production of the mitochondrial ROS [22, 23] which these products could stabilize HIF-1α through inactivation of prolyl hydroxylases [22, 24] .
Interestingly, ROS have been described not only required but also sufficient for stabilization of HIF-1α [25] . Thus, ROS is a key element in tumor angiogenesis and therefore growth and metastasis. In this regard, the effect of oxidative stress and hypoxia were evaluated on expression of TSGA10 and HIF-1α. As results showed, both hypoxia and oxidative-stress induced HIF-1α and reduced TSGA10 expression.
As it has been recently bolded, epigenetic is an important role player in the pathogenesis of breast cancer. Data have shown that acetylation and deacetylation of histones can modify the expression of tumor suppressor genes. Thus, histone deacetylase inhibitors are one of the new targets in breast cancer investigations [26, 27] . The induction of centromere hyper-acetylation by these inhibitors causes the release of heterochromatin proteins and consequently is associated with abnormal chromosome separation and the reduction of abnormal mitosis [28] [29] [30] . Herein, it was shown that treatment of malignant cells with HDACI led to increase in expression of TSGA10 in MCF-7 in all doses. In this cell line, the TSGA10 expression was decreased in low concentration of sodium valproate but increased in high concentration. Although a certain pattern was not found, considering the tumor suppressor function of TSGA10 the hypothesis of its function in histones acetylation/deacetylation is not fully accepted nor rejected.
Conclusion
In this study, it was showed that TSGA10 is down-regulated in tumoral tissues obtained from patients diagnosed with breast cancer when compared to the tumor-free margins (paired controls). Also, this result was confirmed by in-vitro evaluation of two breast cancer cell lines which compared with normal control. Taken together, this study showed that TSGA10 seems to be a tumor suppressor gene, not a CTA. 
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